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Abstract
Background: Unsedated esophagogastroduodenoscopy (EGD) is simpler and safer than sedated EGD; however,
approximately 40% of patients cannot tolerate it. Early identification of patients likely to poorly tolerate unsedated
EGD is valuable for improving compliance. The modified Mallampati classification (MMC) has been used to evaluate
difficult tracheal intubation and laryngoscope insertion. We tried to assess the efficacy of MMC to predict the
tolerance of EGD in unsedated patients.
Methods: Two hundred patients who underwent an unsedated diagnostic EGD were recruited. They were
stratified according to the view of the oropharynx as either MMC class I + II (good view) or class III + IV (poor
view). EGD tolerance was assessed in three ways: gag reflex by endoscopist assessment, patient satisfaction by
interview, and the degree of change in vital signs.
Results: MMC was significantly correlated to gag reflex (P < 0.001), patient satisfaction (P = 0.028), and a change of
vital signs (P = 0.024). Patients in the poor view group had a 3.87-fold increased risk of gag reflex (P < 0.001), a
1.78-fold increased risk of unsatisfaction (P = 0.067), and a 1.96-fold increased risk of a change in vital signs (P =
0.025) compared to those in the good view group.
Conclusions: MMC appears to be a clinically useful predictor of EGD tolerance. Patients with poor view of
oropharynx by MMC criteria may be candidates for sedated or transnasal EGD.
Background
Esophagogastroduodenoscopy (EGD) is a valuable
screening, diagnostic, and therapeutic procedure for the
upper gastrointestinal tract. However, nearly 40% of
patients poorly tolerate unsedated EGD [1], and 10% of
patients experience severe discomfort despite the use
of an ultrathin endoscope [2,3]. Patient discomfort can
interfere with the endoscopist’s judgment and evoke car-
diopulmonary complications, including cardiac arrhyth-
mia, myocardial ischemia, aspiration, and hypoxemia
[4-6]. Sedation can eliminate discomfort and increase
patient compliance with EGD [7,8]. However, sedated
EGD involves more time, monitoring, ancillary person-
nel, and has a higher cardiopulmonary risk than
unsedated EGD [9], and is thus inappropriate for all
patients. Hence, the early identification of patients
potentially intolerant of unsedated EGD would improve
clinical decision-making.
The Mallampati classification was first described in
1985 [10] and modified to include four categories in
1987 [11]. It is based on the poor visualization of the
glottis when the tongue base is disproportionately large
and predicts difficult tracheal intubation and laryngo-
scope insertion. The EGD involves the same route as
tracheal intubation and laryngoscopy, and is associated
with the same discomforts, such as oropharyngeal irrita-
tion, retching, and gag reflex. Therefore, it is reasonable
to link the modified Mallampati classification (MMC)
and peroral EGD tolerance. To test the usefulness of
MMC in clinical practice for routine diagnostic EGD,
we designed the present study to assess the tongue base
size and the view of the oropharynx by using the MMC
to predict EGD tolerance in unsedated patients.
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Patients
From October 2008 to May 2009, two hundred eligible
patients (97 men and 103 women; age 18 - 86 years)
who were not mentally incompetent, did not use seda-
tives or beta-blockers, had not had an emergency endo-
scopic procedure, or a history of oropharyngeal surgery
agreed to participate in the present study. For sample
size calculation, the minimally clinically significant dif-
ference in rates of gag reflex between two MMC groups
w a sc o n s i d e r e dt ob e1 5 % .T h u s6 0p a t i e n t sw e r e
required to give a 90% power to detect a 15% difference
at the 5% significance level for a two-sided test. The
study protocol was approved by the Institutional Review
Board of Tri-Service General Hospital, Taiwan.
Data collection
Before unsedated diagnostic EGD, a written informed
consent and a detailed medical history from patients
were obtained by an endoscopist followed by a face-to-
face interview and MMC status evaluation by two
trained research nurses. Information collected included
age, gender, body mass index (BMI), education (up to
high school; college and above), smoking status, pre-
EGD anxiety, previous EGD experience and satisfaction.
Both patients and endoscopists were blinded to MMC
status.
All patients received 4 puffs of topical pharyngeal
spray containing 10% lidocaine hydrochloride (Xylocaine
Viscous, Astra, Sweden) 5 and 2 minutes before EGD
for a total dosage of 80 mg. Anti-peristaltic agents or
glucagon were not used before EGD. All EGD proce-
dures used Olympus GIF-Q260, XQ260, and XQ240
videoendoscopes with 9.0 - 9.2 mm outer diameter of
distal tip (Olympus Optical Co. Ltd., Tokyo, Japan) in
109, 82, 9 patients respectively, and were performed by
attending endoscopists. Throughout the procedure, non-
invasive mean blood pressure (MBP), pulse rate (PR),
and peripheral oxygen saturation (SaO2) were monitored
with an automated system (Philips, MP20 Junior and
C1, Germany).
After EGD, endoscopists immediately assessed the
presentation of gag reflex and the main diagnosis of
EGD. Patients completed questionnaires prior to leaving
the endoscopy center.
Measurements
Modified Mallampati classification (MMC)
MMC assessment was performed with the patient sitting
upright with his or her mouth maximally opened and
tongue protruded without phonation by two trained
research nurses. The participants were assigned to four
classes (Figure 1): [11]
Class I: Soft palate, fauces, pillars, and uvula are
visible.
Class II: Soft palate, fauces, and uvula are visible.
Class III: Soft palate and base of uvula are visible.
Class IV: Soft palate is not visible at all.
Class I and II were defined as “good view” and III and
IV as “poor view” in the present study.
Reliability of MMC classification between observers
was evaluated by agreement for the independent classifi-
cations of 80 subjects from two observers. Kappa values
were 0.731 and 0.974 for four (I, II, III, IV) and two
(good view and poor view) MMC categories,
respectively.
EGD tolerance assessment
EGD tolerance was evaluated on the basis of endoscopist
assessment, patient satisfaction,a n da change in vital
signs.
Endoscopist assessment
When the endoscopist felt a difficult intubation with inter-
ruption by obvious retching or vomiting, the assessment
for gag reflex was recorded as “present”. The main diagno-
sis were normal, gastroesophageal reflux disease (GERD),
peptic ulcer disease (PUD), and both GERD and PUD.
Patient satisfaction
Information on self-assessed satisfaction was based on
the following questions: “Were you satisfied with the
unsedated EGD?” T h er e s p o n s ew a s“satisfactory” or
“unsatisfactory"; “Would you be willing to undergo
unsedated EGD again?” The response was “yes” or “no”.
A change of vital signs
We recorded MBP, PR, and SaO2 before EGD and when
the endoscope was in the middle third of the esophagus
(about 25 cm from the incisors). A change in vital signs
was defined as an increase in MPB or PR by 20% or
more, or a decrease in SaO2 to 90% or less between the
two recordings.
Statistical analysis
The data are presented as mean ± standard deviation
(SD) or percentage for continuous variables and catego-
rical variables, respectively. The demographic and clini-
cal characteristics of the subjects between groups were
assessed by Student’s t tests (continuous variables) and
chi-square tests (categorical variables). Logistic regres-
sion analyses adjusting for possible covariates were used
to evaluate the relative risk of MMC for the three meth-
ods to assess EGD tolerance. All statistical analyses were
two-tailed. Statistical significance was accepted at 5%
probability level. Analyses were done with the SPSS sta-
tistical analysis program, version 15.0.
Results
The 200 patients had a mean age of 49.2 years and BMI
of 23.6 kg/m
2. In this study, 43.5% patients were college
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EGD anxiety, 64.5% had previously undergone EGD, and
49.6% were satisfied with a previous experience of EGD.
After the EGD, 52.5% patients felt satisfied, 75.5% were
willing to undergo repeat unsedated EGD, 72.5% had no
gag reflex, 52.5% experienced less than 20% MBP eleva-
tion from baseline, 50.0% experienced less than 20% PR
elevation from baseline, and 100% maintained an SaO2
level over 90%. GERD was diagnosed in 67.5% patients,
PUD in 13.5%, and both GERD and PUD in 8.5%, while
10.5% patients were normal (data not shown).
More than 60% (123 out of 200) of patients were in the
poor view group (class III + IV). Patients in the poor
view group had a significantly higher mean BMI than
those in the good view group (class I + II) (24.1 vs.
22.7 kg/m
2; P = 0.01) (Table 1).
The clinical characteristics for different gag reflex sta-
tus, judged by the endoscopist, are shown in Table 2.
Fifty-five (27.5%) patients presented gag reflex during
EGD. The proportion of patients with a poor view of
the oropharynx was significantly higher in the gag reflex
present group than the gag reflex absent group (81.8%
vs. 53.8%, P < 0.001). Moreover, though not significant,
there were more males (58.2% vs. 44.8%), educated
(54.5% vs. 39.3%) and smokers (36.4% vs. 24.1%) in the
gag reflex present group.
More patients with unsatisfactory EGD were found in
the poor view group (45.7% vs. 30.5%, P = 0.028), were
younger (P = 0.012), had no or poor previous EGD
experience (P = 0.004), and had pre-EGD anxiety (38.9%
vs. 17.1%, P = 0.001) (Table 3). The proportion of
patients who had a change in vital signs during EGD was
significantly higher in the poor view group than in the
good view group (67.5% vs. 51.4%, P = 0.024) (Table 4).
The sensitivities and specificities of MMC in predict-
ing the gag reflex, patient satisfaction and a change in
vital signs were 81.8%, 69.5%, 67.5% and 46.2%, 45.7%,
48.6%, respectively (data not shown). After adjusting for
potential covariates, by comparison with patients in the
good view group, those in the poor view group had a
3.87-fold relative risk (95% confidence interval (CI): 1.81 -
8.26, P < 0.001) of experiencing a gag reflex; a 1.78-fold
increased risk of unsatisfaction (95% CI: 0.96 - 3.29,
P = 0.067); a 1.96-fold greater risk of experiencing a
Figure 1 Modified Mallampati classification of oropharyngeal visualization. Class I: Class II: Class III: Class IV.
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(Table 5).
Discussion
Factors associated with poor EGD tolerance include
young age [1,2,12-14], being female [13,15,16], a non-
smoker [17], having low education [13,15], a poor pre-
vious EGD experience [15], and high anxiety prior to
EGD [12,13,15,18,19]. To our knowledge, this report is
the first demonstration that MMC is significantly asso-
ciated with EGD tolerance as defined by endoscopist
assessment, patient satisfaction, or a change in vital
signs. MMC class III + IV can predict patients who are
likely to suffer physical reactions (gag reflex, hyperten-
sion, and tachycardia) during EGD. This simple, fast and
noninvasive method should allow the selection of
patients who require sedated EGD.
EGD tolerance is a complex concept that encompasses
ab r o a dr a n g eo fs p e c i f i cs y m p t o m sa n de x p e c t a t i o n s ,a n d
there is no current consensus on its definition. In our
study, EGD tolerance consisted of three indicators which
reflect assessments by the operator and receiver; objective
reactions and subjective feelings; physical and mental
effects. The willingness to repeat unsedated EGD is
mainly depended on the need of therapy, doctor-patient
relationships (75.5% were willing to repeat unsedated
EGD but only 52.5% patients felt satisfied after the EGD
in our study), or other available methods, such as sedated
and transnasal EGD, which are limited by hospital facility,
underlying conditions, and expenses. Thus, EGD toler-
ance did not include this item. A difficult intubation with
interruption by gag reflex may result in violent peristalsis
with poor images, the missing of minor lesions, gastro-
duodenal spasm with easy trauma by endoscope. Overall,
endoscopist judgement and EGD quality are likely to be
compromised. Endoscopist assessment may be the most
important indicator of EGD tolerance for the clinical
physician. Subjective predictors such as pre-EGD anxiety
[12,13,15,18,19] and previous EGD experience [15] may
be influenced by procedure time, volume of insufflated
air into the stomach, frequent pushing and pulling of the
endoscope, and the doctor-patient relationship. Patient
satisfaction partially depended on the recall from pre-
EGD anxiety and previous EGD experience and cannot,
therefore, be an independent indicator of EGD tolerance.
Our data show that MMC is significantly predictive of
endoscopist assessment of gag reflex and of a change in
vital signs, but not of patient satisfaction.
The tongue is the largest single structure in the oral
cavity, and there is no practical bed-side method to
measure its size objectively. A disproportionately large
Table 1 Comparison of clinical and demographic
characteristics by modified Mallampati classification
(MMC)
MMC class
Descriptor Good view
(n = 77)
Poor view
(n = 123)
P value
Male gender 46.8 49.6 0.696
Mean age (years), mean ± SD 50.7 ± 17.5 48.2 ± 16.0 0.301
BMI (kg/m
2), mean ± SD 22.7 ± 3.4 24.1 ± 3.9 0.010
Up to high school education 58.4 55.3 0.661
Smoker 20.8 31.7 0.092
Previous EGD experience 0.179
No 31.1 38.2
Good 40.3 27.6
Poor 28.6 34.1
Pre-EGD anxiety 26.0 28.5 0.702
EGD diagnosis 0.155
Normal 16.9 7.3
GERD 66.2 68.3
PUD 9.1 13.8
Both (GERD + PUD) 7.8 10.6
Types of endoscope 0.239
Q260 (9.2 mm) 59.7 51.2
XQ260 + XQ240 (9.0 mm) 40.3 48.8
Values reflect % unless otherwise noted. Good view: I + II; Poor view: III + IV;
BMI, body mass index; EGD, esophagogastroduodenoscopy; GERD,
gastroesophageal reflux disease; PUD, peptic ulcer disease.
Table 2 Comparison of clinical and demographic
characteristics by presence of gag reflex
Endoscopist assessment for
gag reflex
Descriptor Absent
(n = 145)
Present
(n = 55)
P value
MMC class, poor view 53.8 81.8 <0.001
Male gender 44.8 58.2 0.092
Mean age (years), mean ± SD 50.2 ± 16.9 46.5 ± 15.5 0.158
BMI (kg/m2), mean ± SD 23.6 ± 3.7 23.4 ± 4.1 0.689
Up to high school education 60.7 45.5 0.052
Smoker 24.1 36.4 0.084
Previous EGD experience 0.324
No 32.4 43.6
Good 34.5 27.3
Poor 33.1 29.1
Pre-EGD anxiety 27.6 27.3 0.965
EGD diagnosis 0.192
Normal 13.1 5.5
GERD 68.3 65.5
PUD 9.7 18.2
Both (GERD + PUD) 9.0 10.9
Types of endoscope 0.520
Q260 (9.2 mm) 53.1 58.2
XQ260 + XQ240 (9.0 mm) 46.9 41.8
Values reflect % unless otherwise noted. MMC, modified Mallampati
classification; Good view: I + II; BMI, body mass index; EGD,
esophagogastroduodenoscopy; GERD, gastroesophageal reflux disease; PUD,
peptic ulcer disease.
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part of the soft palate, overshadow the larynx, and result
in loss of direction and a larger contact surface area for
the EGD. Transnasal EGD is not passed through the
oral cavity and greatly decrease the oropharyngeal irrita-
tion, such as choking, gag reflex, and sympathetic ner-
vous activity [20,21]. Therefore, MMC can readily assess
the view of the oropharyngeal space and accurately
select candidates for the transnasal EGD.
We have compared the patient profile and diagnosis by
status favorability within each of the three EGD tolerance
measures, which has not been done collectively in pre-
vious studies. Both pre-EGD anxiety and previous EGD
experience were only associated with patient satisfaction.
Pre-EGD anxiety was related to previous EGD experi-
ence. In the present study, only 9.2% of patients with a
good previous EGD experience suffered pre-EGD anxiety,
which was less than those with a poor (40.6%) or no past
experience (32.4%) (data not shown). Thus, an earlier
positive EGD experience helps provide for low pre-EGD
anxiety and improve satisfaction in a future EGD. Same
as the previous study [22], our older patients have less
oropharyngeal sensitivity and well tolerate to EGD proce-
dure. The role of gender in EGD tolerance has been con-
troversial [8,16]. Females report less satisfaction and
males more frequently experience a gag reflex in our
study. Contrary to previous studies [13,15], we found that
patients with a higher education level had less satisfaction
and more instances of gag reflex than those with a lower
education level. This finding may be attributable to
younger age (41.7 vs. 54.9 years) and to a predominance
of males (59.8% vs. 39.8%). We, unlike other studies, did
not find association between EGD tolerance and any of
BMI, smoking status, types of endoscope, or EGD diag-
nosis. There are no studies discussing the association
between the depth of mucosal injury and the EGD toler-
ance before. We inferred that superficial mucosal injury
like atrophic gastritis or Helicobacter pylori related gastri-
tis less affects the EGD tolerance as well as PUD with
deeper mucosal injury. However, it is needed to be
proved by further prospective studies in the future.
Ways of managing our findings might emerge from
procedural and technical advances. Patients with the
poor view of the oropharynx regardless of anxiety traits
and EGD experiences, might be candidates for more
widely acceptable methods for sedated EGD. Patients in
whom the view is poor and unwilling or unsuitable for
current methods of sedation, could have transnasal EGD
with an ultrathin endoscope, more topical pharyngeal
Table 4 Association between patients’ clinical and
demographic characteristics and a change in vital signs
A change in vital signs
(≥20%)
Descriptor No
(n = 74)
Yes
(n = 126)
P value
MMC class, poor view 51.4 67.5 0.024
Male gender 50.0 47.6 0.745
Mean age (years), mean ± SD 52.2 ± 17.2 47.4 ± 16.0 0.050
BMI (kg/m
2), mean ± SD 23.8 ± 4.1 23.5 ± 3.6 0.578
Up to high school education 58.1 55.6 0.725
Smoker 77.0 69.8 0.272
Previous EGD experience 0.469
No 36.5 34.9
Good 36.5 30.2
Poor 27.0 34.9
Pre-EGD anxiety 31.1 25.4 0.385
EGD diagnosis 0.203
Normal 13.5 9.5
GERD 64.9 69.0
PUD 16.2 9.5
Both (GERD + PUD) 5.4 11.9
Types of endoscope 0.623
Q260 (9.2 mm) 56.8 53.2
XQ260 + XQ240 (9.0 mm) 43.2 46.8
Values reflect % unless otherwise noted. MMC, modified Mallampati
classification; Good view: I + II; BMI, body mass index; EGD,
esophagogastroduodenoscopy; GERD, gastroesophageal reflux disease; PUD,
peptic ulcer disease.
Table 3 Comparison of clinical and demographic
characteristics by patient satisfaction status
Patient satisfaction
Descriptor Satisfactory
(n = 105)
Unsatisfactory
(n = 95)
P value
MMC class, poor view 54.3 69.5 0.028
Male gender 51.4 45.3 0.384
Mean age (years), mean ± SD 51.9 ± 16.5 46.1 ± 16.2 0.012
BMI (kg/m
2), mean ± SD 23.8 ± 3.7 23.4 ± 3.9 0.447
Up to high school education 62.9 49.5 0.057
Smoker 72.4 72.6 0.968
Previous EGD experience 0.004
No 30.5 41.1
Good 42.9 21.1
Poor 26.7 37.9
Pre-EGD anxiety 17.1 38.9 0.001
EGD diagnosis 0.850
Normal 11.4 10.5
GERD 69.5 65.3
PUD 10.5 13.7
Both (GERD + PUD) 8.6 10.5
Types of endoscope 0.949
Q260 (9.2 mm) 54.3 54.7
XQ260 + XQ240 (9.0 mm) 45.7 45.3
Values reflect % unless otherwise noted. MMC, modified Mallampati
classification; Good view: I + II; BMI, body mass index; EGD,
esophagogastroduodenoscopy; GERD, gastroesophageal reflux disease; PUD,
peptic ulcer disease.
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tion or head-neck posture. There are several limitations
in this study. First, our findings may not applicable to
morbidly obese patients who tend to be in MMC class
III + IV. These patients are likely to have comorbidities
such as cardiovascular diseases, the obesity hypoventila-
tion syndrome, and obstructive sleep apnea [23,24], and
may be more safely examined by unsedated transnasal
EGD than having sedated EGD [25]. Second, our study
investigated diagnostic EGD without interventional pro-
cedures. Intravenous sedation is standard practice and
an even better option in the performance of therapeutic
EGD [26]. Finally, like a previous report of tracheal intu-
bation and laryngoscopy [27], we observed that MMC
has good sensitivity (0.68 - 0.82), but poor discrimina-
tive power in predicting EGD tolerance. Combination
with other predictors may add further diagnostic value
to the use of MMC.
Conclusions
EGD is an inevitably unpleasant procedure but EGD tol-
erance is different for each patient. In conclusion, we
have demonstrated that MMC is a clinically useful tool
in the prediction of EGD tolerance in unsedated
patients. Patients with a poor view of the oropharynx
need consideration for sedated or transnasal EGD.
Additional files
Letter of approval by Institutional Review Board of Tri-
Service General Hospital.
Acknowledgements
This study was supported in part by grant from the Foundation for Medical
Research of Tri-Service General Hospital (TSGH-C97-45; TSGH-C98-47) and
National Defense Medical Center (NDMC-P98-37).
Author details
1Division of Gastroenterology, Department of Internal Medicine, Tri-Service
General Hospital, National Defense Medical Center, Taiwan.
2School of Public
Health, National Defense Medical Center, Taiwan.
Authors’ contributions
HHH conceived of the study, involved in its design and coordination and
drafted the manuscript. YLS, HCC, and TYH participated in the sequence
alignment and helped to collect data. MShL participated in its design and
performed the statistical analysis. TYH revised it critically for important
intellectual content and helped to draft the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 7 October 2010 Accepted: 15 February 2011
Published: 15 February 2011
References
1. Abraham N, Barkun A, Larocque M, Fallone C, Mayrand S, Baffis V, Cohen A,
Daly D, Daoud H, Joseph L: Predicting which patients can undergo upper
endoscopy comfortably without conscious sedation. Gastrointest Endosc
2002, 56:180-189.
2. Zaman A, Hapke R, Sahagun G, Katon RM: Unsedated peroral endoscopy
with a video ultrathin endoscope: patient acceptance, tolerance, and
diagnostic accuracy. Am J Gastroenterol 1998, 93:1260-1263.
3. Mulcahy HE, Kelly P, Banks MR, Connor P, Patchet SE, Farthing MJ,
Fairclough PD, Kumar PJ: Factors associated with tolerance to, and
discomfort with, unsedated diagnostic gastroscopy. Scand J Gastroenterol
2001, 36:1352-1357.
4. Waring JP, Baron TH, Hirota WK, Goldstein JL, Jacobson BC, Leighton JA,
Mallery JS, Faigel DO: Guidelines for conscious sedation and monitoring
during gastrointestinal endoscopy. Gastrointest Endosc 2003, 58:317-322.
5. Levy N, Abinader E: Continuous electrocardiographic monitoring with
Holter electrocardiocorder throughout all stages of gastroscopy. Am J
Dig Dis 1977, 22:1091-1096.
6. Quine MA, Bell GD, McCloy RF, Charlton JE, Devlin HB, Hopkins A:
Prospective audit of upper gastrointestinal endoscopy in two regions of
England: safety, staffing, and sedation methods. Gut 1995, 36:462-467.
7. Fisher NC, Bailey S, Gibson JA: A prospective, randomized controlled trial
of sedation vs. no sedation in outpatient diagnostic upper
gastrointestinal endoscopy. Endoscopy 1998, 30:21-24.
8. Froehlich F, Schwizer W, Thorens J, Kohler M, Gonvers JJ, Fried M:
Conscious sedation for gastroscopy: patient tolerance and
cardiorespiratory parameters. Gastroenterology 1995, 108:697-704.
9. Lazzaroni M, Bianchi PG: Preparation, premedication, and surveillance.
Endoscopy 2005, 37:101-109.
10. Mallampati SR, Gatt SP, Gugino LD, Desai SP, Waraksa B, Freiberger D,
Liu PL: A clinical sign to predict difficult tracheal intubation: a
prospective study. Can Anaesth Soc J 1985, 32:429-434.
11. Samsoon GL, Young JR: Difficult tracheal intubation: a retrospective
study. Anaesthesia 1987, 42:487-490.
12. Tan CC, Freeman JG: Throat spray for upper gastrointestinal endoscopy is
quite acceptable to patients. Endoscopy 1996, 28:277-282.
13. Mahajan RJ, Johnson JC, Marshall JB: Predictors of patient cooperation
during gastrointestinal endoscopy. J Clin Gastroenterol 1997, 24:220-223.
14. Farhadi A, Fields JZ, Hoseini SH: The assessment of
esophagogastroduodenoscopy tolerance a prospective study of 300
cases. Diagn Ther Endosc 2001, 7:141-147.
15. Campo R, Brullet E, Montserrat A, Calvet X, Moix J, Rue M, Roque M,
Donoso L, Bordas JM: Identification of factors that influence tolerance of
upper gastrointestinal endoscopy. Eur J Gastroenterol Hepatol 1999,
11:201-204.
16. Dumortier J, Napoleon B, Hedelius F, Pellissier PE, Leprince E, Pujol B,
Ponchon T: Unsedated transnasal EGD in daily practice: results with 1100
consecutive patients. Gastrointest Endosc 2003, 57:198-204.
17. Gelly AL, Farley A, Boyer J, Asselin M, Spenard J: Influence of sex, age and
smoking status on patient comfort during gastroscopy with pharyngeal
anesthesia by a new benzocaine-tetracaine preparation. Can J
Gastroenterol 1998, 12:431-433.
Table 5 Odds ratio (OR) and 95% confidence interval (CI) for esophagogastroduodenoscopy tolerance by modified
Mallampati classification (MMC)
MMC status, OR (95% CI)
Good view Poor view P value
Endoscopist assessment for gag reflex (present vs. absent) 1 3.87 (1.81 - 8.26) <0.001
Patient satisfaction (unsatisfactory vs. satisfactory) 1 1.78 (0.96 - 3.29)† 0.067
A change of vital signs (yes vs. no) 1 1.96 (1.09 - 3.54) 0.025
†Adjusting for age, previous EGD experience, and pre-EGD anxiety. Good view: I + II; Poor view: III + IV.
Huang et al. BMC Gastroenterology 2011, 11:12
http://www.biomedcentral.com/1471-230X/11/12
Page 6 of 718. Soma Y, Saito H, Kishibe T, Takahashi T, Tanaka H, Munakata A: Evaluation
of topical pharyngeal anesthesia for upper endoscopy including factors
associated with patient tolerance. Gastrointest Endosc 2001, 53:14-18.
19. Faulx AL, Catanzaro A, Zyzanski S, Cooper GS, Pfau PR, Isenberg G,
Wong RC, Sivak MV Jr, Chak A: Patient tolerance and acceptance of
unsedated ultrathin esophagoscopy. Gastrointest Endosc 2002, 55:620-623.
20. Dean Robert, Kulwinder Dua, Massey Benson, Berger William, Walter J,
Hogan , Reza Shaker: A comparative study of unsedated transnasal
esophagogastroduodenoscopy and conventional EGD. Gastrointest Endosc
1996, 44:422-424.
21. Yagi J, Adachi K, Arima N, Tanaka S, Ose T, Azumi T, Sasaki H, Sato M,
Kinoshita Y: A prospective randomized comparative study on the safety
and tolerability of transnasal esophagogastroduodenoscopy. Endoscopy
2005, 37:1226-1231.
22. Davies AE, Kidd D, Stone SP, MacMahon J: Pharyngeal sensation and gag
reflex in healthy subjects. Lancet 1995, 345:487-488.
23. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M,
Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk
factors associated with myocardial infarction in 52 countries (the
INTERHEART study): case-control study. Lancet 2004, 364:937-952.
24. Poulain M, Doucet M, Major GC, Drapeau V, Series F, Boulet LP, Tremblay A,
Maltais F: The effect of obesity on chronic respiratory diseases:
pathophysiology and therapeutic strategies. CMAJ 2006, 174:1293-1299.
25. Adams JP, Murphy PG: Obesity in anaesthesia and intensive care. Br J
Anaesth 2000, 85:91-108.
26. Faigel DO, Baron TH, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF,
Leighton JA, Mallery JS, Peterson KA, Waring JP, Fanelli RD, Wheeler-
Harbaugh J: Guidelines for the use of deep sedation and anesthesia for
GI endoscopy. Gastrointest Endosc 2002, 56:613-617.
27. Restelli L, Moretti MP, Todaro C, Banfi L: The Mallampati’s scale: a study of
reliability in clinical practice. Minerva Anestesiol 1993, 59:261-265.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-230X/11/12/prepub
doi:10.1186/1471-230X-11-12
Cite this article as: Huang et al.: Modified mallampati classification as a
clinical predictor of peroral esophagogastroduodenoscopy tolerance. BMC
Gastroenterology 2011 11:12.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Huang et al. BMC Gastroenterology 2011, 11:12
http://www.biomedcentral.com/1471-230X/11/12
Page 7 of 7